Olfson E, Saccone NL, Johnson EO, Chen LS, Culverhouse R, Doheny K, Foltz SM, Fox L, Gogarten SM, Hartz S, Hetrick K, Laurie CC, Marosy B, Amin N, Arnett D, Barr RG, Bartz TM, Bertelsen S, Borecki IB, Brown MR, Chasman DI, van Duijn CM, Feitosa MF, Fox ER, Franceschini N, Franco OH, Grove ML, Guo X, Hofman A, Kardia SL, Morrison AC, Musani SK, Psaty BM, Rao DC, Reiner AP, Rice K, Ridker PM, Rose LM, Schick UM, Schwander K, Uitterlinden AG, Vojinovic D, Wang JC, Ware EB, Wilson G, Yao J, Zhao W, Breslau N, Hatsukami D, Stitzel JA, Rice J, Goate A, Bierut LJ (2016) <br />Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans<br /><i>Mol Psychiatry</i> <b>21</b>: 601<br /><br />Manar MH, Brown MR, Gauthier TW, Brown LA (2004) <br />Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia<br /><i>J Perinatol</i> <b>24</b>: 30<br /><br />Allen R, Boublik J, Hauger RL, Scott N, Rivier J, Brown MR (1991) <br />Neuropeptide Y radio-immunoassay: characterization and application<br /><i>Clinical & Experimental Pharmacology & Physiology</i> <b>18</b>: 825<br /><br />